Switzerland Approves Moderna Vaccine for Adolescents
[Asia Economy Reporter Changhwan Lee] On the 9th (local time), Switzerland approved the use of Moderna's COVID-19 vaccine for adolescents aged 12 to 17, according to foreign media reports.
The Swissmedic, the pharmaceutical regulatory authority, stated that in studies conducted on this age group, the Moderna vaccine showed 93% efficacy.
The authority explained, "This vaccine showed a similar immune response compared to young adults aged 18 to 25."
Earlier, Switzerland approved the use of Pfizer's COVID-19 vaccine for adolescents in June.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Switzerland, with a total population of about 8.7 million, has a COVID-19 vaccination completion rate of approximately 49%.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
